Nitration enhances the allergenic potential of proteins

International Archives of Allergy and Immunology

Volumn 141, Issue 3, 2006, Pages 265-275

  Gruijthuijsen, Y K ^a   Grieshuber, I ^a   Stocklinger A ^a   Tischlera, U ^a   Fehrenbach, T ^b   Weller, M G ^b   Vogel, L ^c   Vieths, S ^c   Poschl U ^b   Duschl, Albert ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Air pollution; Bet v 1; Epitopes; Immunoglobulin E; Nitration; Nitrotyrosine; Ovalbumin

Indexed keywords

ANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 5; OVALBUMIN; PROTEIN; PROTEIN BET V 1A; UNCLASSIFIED DRUG;

AIR POLLUTION; ALLERGENICITY; ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIRCH; CELL PROLIFERATION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; INTERFERON PRODUCTION; MOUSE; NITRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; URBAN AREA;

ALLERGENS; ANIMALS; ANTIGENS, PLANT; CELL PROLIFERATION; FEMALE; FOOD HYPERSENSITIVITY; MICE; MICE, INBRED BALB C; OVALBUMIN; PLANT PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPLEEN; TETRANITROMETHANE; TYROSINE;

EID: 33750187545     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095296     Document Type: Article

References (28)

1. Bernstein JA, Alexis N, Barnes C, Bernstein IL, Nel A, Peden D, Diaz-Sanchez D, Tarlo SM, Williams PB: Health effects of air pollution. J Allergy Clin Immunol 2004;114:1116-1123.
2. Bommel H, Li-Weber M, Serfling E, Duschl A: The environmental pollutant pyrene induces the production of IL-4. J Allergy Clin Immunol 2000;105:796-802.
3. D'Amato G: Urban air pollution and plant-derived respiratory allergy. Clin Exp Allergy 2000;30:628-636.
4. Saxon A, Diaz-Sanchez D: Air pollution and allergy: you are what you breathe. Nat Immunol 2005;6:223-226.
5. 2: the gas that won't go away. Clin Exp Allergy 2001;31:1170-1172.
6. Franze T, Weller MG, Niessner R, Pöschl U: Protein nitration by polluted air. Environ Sci Technol 2005;39:1673-1678.
7. Doyle HA, Mamula MJ: Posttranslational modifications of self-antigens. Ann NY Acad Sci 2005;1050:1-9.
8. Ferreira F, Ebner C, Kramer B, Casari G, Briza P, Kungl AJ, Grimm R, Jahn-Schmid B, Breiteneder H, Kraft D, Breitenbach M, Rheinberger HJ, Scheiner O: Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998;12:231-242.
9. Spangfort MD, Mirza O, Ipsen H, Van Neerven RJ, Gajhede M, Larsen JN: Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis. J Immunol 2003;171:3084-3090.
10. Greenacre SA, Ischiropoulos H: Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001;34:541-581.
11. Birnboim HC, Lemay AM, Lam DK, Goldstein R, Webb JR: Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J Immunol 2003;171:528-532.
12. Ohmori H, Oka M, Nishikawa Y, Shigemitsu H, Takeuchi M, Magari M, Kanayama N: Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine. Immunol Lett 2005;96:47-54.
13. Peplow M: Traffic pollution revs up allergens. News@Nature.com2005;DOI: 10.1038/news050131-16.
14. Franze T, Weller MG, Niessner R, Pöschl U: Enzyme immunoassays for the investigation of protein nitration by air pollutants. Analyst 2003;128:824-831.
15. Franze T, Weller MG, Niessner R, Pöschl U: Comparison of nitrotyrosine antibodies and development of immunoassays for the detection of nitrated proteins. Analyst 2004;129:589-596.
16. Walcher W, Franze T, Weller MG, Pöschl U, Huber CG: Liquid- and gas-phase nitration of bovine serum albumin studied by LC-MS and LC-MS/MS using monolithic columns. J Proteome Res 2003;2:534-542.
17. Murphy KM, Heimberger AB, Loh DY: Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990;250:1720-1723.
18. Hochreiter R, Stepanoska T, Ferreira F, Valenta R, Vrtala S, Thalhamer J, Hartl A: Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen. Eur J Immunol 2003;33:1667-1676.
19. Hoffmann A, Kaul S, Fotisch K, Danz N, Luttkopf D, Hatahet L, Kastner B, Vogel L, Holtz G, Vieths S: Mediator release assays based on human and murine IgE: potential and limitations in allergen standardization. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003:76-85; discussion 85-86.
20. Hartl A, Weiss R, Hochreiter R, Scheiblhofer S, Thalhamer J: DNA vaccines for allergy treatment. Methods 2004;32:328-339.
21. Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, Burkhardt H, Holmdahl R: Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002;99:9960-9965.
22. Pierce RA, Field ED, den Haan JM, Caldwell JA, White FM, Marto JA, Wang W, Frost LM, Blokland E, Reinhardus C, Shabanowitz J, Hunt DF, Goulmy E, Engelhard VH: Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol 1999;163:6360-6364.
23. Zarling AL, Ficarro SB, White FM, Shabanowitz J, Hunt DF, Engelhard VH: Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med 2000;192:1755-1762.
24. Breiteneder H, Friedl-Hajek R, Ebner C, Schenk S, Fischer G, Kraft D, Scheiner O: Sequence comparisons of the CDR3 hypervariable loops of human T cell receptors specific for three major T cell epitopes of the birch pollen allergen Bet v 1. Mol Immunol 1996;33:1039-1048.
25. Ebner C, Szepfalusi Z, Ferreira F, Jilek A, Valenta R, Parronchi P, Maggi E, Romagnani S, Scheiner O, Kraft D: Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993;150:1047-1054.
26. Friedl-Hajek R, Spangfort MD, Schou C, Breiteneder H, Yssel H, Joost van Neerven RJ: Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons. Clin Exp Allergy 1999;29:478-487.
27. Jahn-Schmid B, Radakovics A, Luttkopf D, Scheurer S, Vieths S, Ebner C, Bohle B: Bet v 1142-1156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J Allergy Clin Immunol 2005;116:213-219.
28. Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, Hoffmann-Sommergruber K, Scheiner O, Kraft D, Breitenbach M, Rheinberger HJ, Ebner C: Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.